- Previous Close
0.3900 - Open
0.3800 - Bid 0.3500 x --
- Ask 0.3750 x --
- Day's Range
0.3550 - 0.3800 - 52 Week Range
0.2050 - 0.4800 - Volume
152,996 - Avg. Volume
353,408 - Market Cap (intraday)
36.272M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Jan 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.52
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. The company's smartphone-based application serves as a device for conducting neurobehavioral evaluations. Its application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Sydney, Australia.
www.blinklab.org--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: BB1.AX
View MorePerformance Overview: BB1.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BB1.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BB1.AX
View MoreValuation Measures
Market Cap
36.27M
Enterprise Value
32.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
7.79
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-70.87%
Return on Equity (ttm)
-130.35%
Revenue (ttm)
194.87k
Net Income Avi to Common (ttm)
-3.84M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
4.4M
Total Debt/Equity (mrq)
3.20%
Levered Free Cash Flow (ttm)
-1.57M